David Blaisdell

Research Reports

Measuring Telehealth Quality in Cancer Care: We Don’t Know What We Don’t Know

11/15/2022

David Blaisdell

Tom Valuck, MD, JD

The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...

The authors evaluate key quality...

11/15/2022

Journal of Clinical Pathways

Viewpoint

Catch Me If You Can: Aligning Quality Measurement With Oncology Innovation

12/17/2019

Tom Valuck, MD, JD—Blog Editor

David Blaisdell

Theresa Schmidt, MA

Breakthrough treatments in cancer care, including precision therapies tailored to specific patient factors, are driving rapid changes in the definitions of oncology quality and value. Efforts to implement value-based...

...

12/17/2019

Journal of Clinical Pathways